Clin Chest Med. 2023 Sep;44(3):575-584. doi: 10.1016/j.ccm.2023.06.003.
ABSTRACT
Interstitial lung disease (ILD), a clinically recognized group of diseases resulting in pulmonary fibrosis, affects up to 200 individuals per 100,000 in the United States. Sarcoidosis has a wide range of clinical manifestations including pulmonary fibrosis. Health disparities are prevalent in both ILD and sarcoidosis around socioeconomic status, race, gender, and geographic location. This review outlines the known health disparities, discusses possible determinants of disparities, and outlines a path to achieve equity in ILD and sarcoidosis.
PMID:37517836 | DOI:10.1016/j.ccm.2023.06.003